Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsBuildingsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLand & ImprovementsLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Core Laboratories (CLB) Liabilities and Shareholders Equity (2022 - 2026)

Core Laboratories filings provide 5 years of Liabilities and Shareholders Equity readings, the most recent being $587.7 million for Q1 2026.

  • On a quarterly basis, Liabilities and Shareholders Equity changed 0.25% to $587.7 million in Q1 2026 year-over-year; TTM through Mar 2026 was $2.4 billion, a 0.19% change, with the full-year FY2025 number at $584.0 million, changed 0.19% from a year prior.
  • Liabilities and Shareholders Equity hit $587.7 million in Q1 2026 for Core Laboratories, up from $584.0 million in the prior quarter.
  • In the past five years, Liabilities and Shareholders Equity ranged from a high of $602.1 million in Q2 2025 to a low of $570.2 million in Q3 2022.
  • Median Liabilities and Shareholders Equity over the past 5 years was $589.5 million (2025), compared with a mean of $589.6 million.
  • Biggest five-year swings in Liabilities and Shareholders Equity: rose 4.21% in 2023 and later dropped 1.93% in 2025.
  • Core Laboratories' Liabilities and Shareholders Equity stood at $578.4 million in 2022, then grew by 1.39% to $586.4 million in 2023, then decreased by 0.22% to $585.1 million in 2024, then decreased by 0.19% to $584.0 million in 2025, then grew by 0.64% to $587.7 million in 2026.
  • The last three reported values for Liabilities and Shareholders Equity were $587.7 million (Q1 2026), $584.0 million (Q4 2025), and $591.4 million (Q3 2025) per Business Quant data.